verapamil hydrochloride
Generic: verapamil hydrochloride
Labeler: mylan pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
verapamil hydrochloride
Generic Name
verapamil hydrochloride
Labeler
mylan pharmaceuticals inc.
Dosage Form
CAPSULE, EXTENDED RELEASE
Routes
Active Ingredients
verapamil hydrochloride 120 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0378-6320
Product ID
0378-6320_c63ca9bc-5c77-4e53-8adf-9cfd16bfe012
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075138
Listing Expiration
2026-12-31
Marketing Start
1999-05-20
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
03786320
Hyphenated Format
0378-6320
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
verapamil hydrochloride (source: ndc)
Generic Name
verapamil hydrochloride (source: ndc)
Application Number
ANDA075138 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 120 mg/1
Packaging
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-6320-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c63ca9bc-5c77-4e53-8adf-9cfd16bfe012", "openfda": {"upc": ["0303786380015", "0303786320011", "0303786440016"], "unii": ["V3888OEY5R"], "rxcui": ["897612", "897618", "897624"], "spl_set_id": ["c86084bc-33aa-eece-5a96-6c0dad2d1a32"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-6320-01)", "package_ndc": "0378-6320-01", "marketing_start_date": "19990520"}], "brand_name": "Verapamil Hydrochloride", "product_id": "0378-6320_c63ca9bc-5c77-4e53-8adf-9cfd16bfe012", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "0378-6320", "generic_name": "verapamil hydrochloride", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA075138", "marketing_category": "ANDA", "marketing_start_date": "19990520", "listing_expiration_date": "20261231"}